Agios Pharmaceuticals Inc. buy Royal Bank of Canada
Start price
16.02.24
/
50%
€24.80
Target price
16.02.25
€38.99
Performance (%)
48.39%
Price
03.10.24
€36.80
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Agios Pharmaceuticals Inc. has seen massive gains of 48.39%. This prediction currently runs until 16.02.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Agios Pharmaceuticals Inc. | -10.244% | -10.244% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Agios Pharmaceuticals Inc. diskutieren
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) had its price target lowered by analysts at Royal Bank of Canada from $43.00 to $42.00. They now have an "outperform" rating on the stock.
Ratings data for AGIO provided by MarketBeat
Stopped prediction by Royal_Bank_of_Canada for Agios Pharmaceuticals Inc.
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€43.00
19.09.24
19.09.24
€49.40
19.09.25
19.09.25
-14.42%
03.10.24
03.10.24
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€40.40
02.08.24
02.08.24
€50.39
02.08.25
02.08.25
-8.91%
03.10.24
03.10.24
Agios Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€42.20
04.06.24
04.06.24
€48.75
04.06.25
04.06.25
-12.80%
03.10.24
03.10.24